Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents

Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents

Abstract Introduction Although the combination of venetoclax (VEN) and hypomethylating agents (HMAs) results in impressive efficacy in acute myeloid leukemia (AML), there is still a subset of patients who are refractory. We investigated the outcomes of AML patients with monocytic differentiation who...

Full description

Saved in:
Bibliographic Details
Main Authors: Dian Jin, Jingsong He, Haoguang Chen, Wenjun Wu, Xiaoyan Han, Jing Le, Wenxiu Shu, Qianqian Yang, Shanshan Pei, Zhen Cai, Donghua He
Format: Article
Language:English
Published: Wiley 2024-07-01
Series:Cancer Medicine
Subjects:
acute myeloid leukemia
cancer risk factor
prognosis
targeted therapy
Online Access:https://doi.org/10.1002/cam4.7378
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.7378

Similar Items